Small intestinal physiology relevant to bariatric and metabolic endoscopic therapies: Incretins, bile acid signaling, and gut microbiome
Authors:
- Nienke van OlstNONienke van Olst
- Suzanne MeiringSMSuzanne Meiring
- Maurits de BrauwMBMaurits de Brauw
- Jacques J.G.H.M. BergmanJBJacques J.G.H.M. Bergman
- Max NieuwdorpMNMax Nieuwdorp
- Donald L. van der PeetDPDonald L. van der Peet
- Victor E.A. GerdesVGVictor E.A. Gerdes
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Techniques and Innovations in Gastrointestinal Endoscopy
- Vol. 22 (3) , 109-119
Abstract
No abstract availableThis publication has 154 references indexed in Scilit:
- Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studiesDiabetologia, 2013
- Antibiotics in early life alter the murine colonic microbiome and adiposityNature, 2012
- FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α PathwayCell Metabolism, 2011
- Systemic gut microbial modulation of bile acid metabolism in host tissue compartmentsProceedings of the National Academy of Sciences, 2010
- Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43Nature, 2009
- Human gut microbiome adopts an alternative state following small bowel transplantationProceedings of the National Academy of Sciences, 2009
- TGR5-Mediated Bile Acid Sensing Controls Glucose HomeostasisCell Metabolism, 2009
- Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41Proceedings of the National Academy of Sciences, 2008
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Obesity alters gut microbial ecologyProceedings of the National Academy of Sciences, 2005